{'fraction_non_alphanumeric': 0.041396103896103896, 'fraction_numerical': 0.020292207792207792, 'mean_word_length': 4.708333333333333, 'pattern_counts': {'":': 0, '<': 4, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF THE INTRAHIPPOCAMPAL CO-INJECTION OF ß-AMYLOID PROTEIN1-40 AND IBOTENIC ACID IN RATS

The authors investigated the effects of bilateral intrahippocampal co-injection of Aβ1-40 (4 µg for each side) with ibotenic acid (Ibo, 2 µg for each side) on rats' performance in the open field behavior, Y-maze, and passive avoidance task, and also examined some neurochemical changes in hippocampus two weeks after the co-injection. The results showed that the co-injection of Aβ1-40 with Ibo induced a decrease in exploratory activity and a significant decline in learning-memory ability of the tested rats (p <. 01). The neurochemistry changes induced by the co-injection included a significant decreased in membrane fluidity of hippocampal mitochondria (p <. 01), a significant decrease in the activity of SOD (p <. 01), and a remarkable increase in the content of MDA (p <. 01). These results suggest that the co-injection of Aβ1-40 with Ibo may induce an increase of hippocampal damage by peroxidation, and a serious learning and memory impairment of the rats. The results also suggest that the co-injection of Aβ1-40 with Ibo may provide a useful animal model for Alzheimer's disease (AD) research.